Identification
Personal identification
- Full name
- Samie Jaffrey
Citation names
- Jaffrey S.R
Author identifiers
- Ciência ID
- D816-9E7A-6E4C
- ORCID iD
- 0000-0003-3615-6958
Telephones
- Fax
-
- (+1) 2127466241 (Professional)
- Telephone
-
- (+1) 2127466243 (Professional)
Addresses
- Department of Pharmacology Weill Medical College, Cornell University 1300 York Avenue, Box 70 , NY 10065 , New York, New York, United States (Professional)
Websites
- https://www.jaffreylab.org/ (Professional)
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Neurosciences
- Natural sciences - Biological Sciences - Biochemical Research Methods
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English (Mother tongue) |
Education
Degree | Classification | |
---|---|---|
1999/06 - 2001/06
Concluded
|
Chemical biology of protein modifications by nitric oxide/ Proteomic characterization of nitric oxide signaling (Pós-doutoramento)
Johns Hopkins University, United States
|
|
1993/07 - 1999/06
Concluded
|
Medicine (Doctor)
Johns Hopkins University, United States
"Cloning and characterization of proteins that bind and regulate neuronal nitric oxide synthase" (THESIS/DISSERTATION)
|
|
1999/06
Concluded
|
Neuroscience (Doutoramento)
Johns Hopkins University School of Medicine, United States
|
|
1992/05
Concluded
|
Biology (Bachelor)
Massachusetts Institute of Technology, United States
"Metal binding properties of the HIV-1 RNA-binding protein Tat" (THESIS/DISSERTATION)
|
Affiliation
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2012 - Current | Full Professor (University Teacher) | Weill Cornell Medicine, United States |
Cornell University, United States | ||
2006 - 2012 | Associate Professor (University Teacher) | Weill Cornell Medicine, United States |
Cornell University, United States | ||
2001 - 2006 | Assistant Professor (University Teacher) | Weill Cornell Medicine, United States |
Cornell University, United States |
Others
Category Host institution |
Employer | |
---|---|---|
2016 - Current | present Member | The American Society for Clinical Investigation, United States |
2003 - Current | Mass Spectrometry Facility Oversight Committee | Weill Cornell Medicine Department of Pharmacology, United States |
2002 - Current | Pharmacology Graduate Program Curriculum committee | Weill Cornell Medicine, United States |
Weill Cornell Medicine Department of Pharmacology, United States | ||
2013 - 2016 | Weill Cornell Committee of Review (for promotions and tenure) | Weill Cornell Medicine, United States |
2015 - 2015 | Weill Cornell Basic Science Faculty Recruitment Committee | Weill Cornell Medicine, United States |
2008 - 2010 | Neurodegenerative disorders faculty recruitment committee | Weill Cornell Medicine Alzheimer's Disease and Memory Disorders Program, United States |
2008 - 2009 | Postdoctoral policy advisory committee | Weill Cornell Medicine, United States |
2004 - 2006 | General Faculty Council, Pharmacology Department Representative | Weill Cornell Medicine Department of Pharmacology, United States |
2004 - 2006 | General Faculty Council, Pharmacology Department Representative | Weill Cornell Medicine, United States |
2004 - 2005 | Support Services and Campus Life Work Group (Strategic Plan III) | Weill Cornell Medicine, United States |
2003 - 2003 | Weill Cornell Graduate School Dean search committee | Weill Cornell Graduate School of Medical Sciences, United States |
Projects
Grant
Designation | Funders | |
---|---|---|
2014/09/10 - 2019/08/31 | Control of cap-independent translation by N6-methyladenosine and FTO
info:eu-repo/grantAgreement/NIH/NATIONAL CANCER INSTITUTE/5R01CA186702-05/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health |
2014/06/01 - 2019/05/31 | Pathways controlling mRNA translation pathways in dopaminergic neurons
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE ON DRUG ABUSE/1R01DA037755-01/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2009/05/15 - 2019/05/31 | Engineering RNA-activated fluorescence switches for imaging RNA and RNA biology
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE/5R01NS064516-07/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2015/09/23 - 2018/06 | LIPS: A novel technology for spatial and temporal control of protein synthesis in dendritic spines
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF MENTAL HEALTH/5U01MH109087-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2015/01/01 - 2017/12/31 | DNA helicases as mediators of trinucleotide-repeat pathology in fragile X syndrome
2014-015
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2013/09/15 - 2017/08/31 | mRNA methylation: A novel mechanism that blocks signaling by drugs of abuse
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE ON DRUG ABUSE/5R01DA037150-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health |
2006/07/01 - 2017/05/31 | Uncovering polyadenylation pathways in neuronal signaling
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE/5R01NS056306-08/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2014/09/01 - 2016/08/31 | Live imaging of the RNA hexanucleotide repeat expansion in C9ORF72-linked ALS to enable therapeutic screening and development
W81XWH-14-1-0427
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
US Department of Defense
Concluded
|
2014/04/01 - 2016/03/31 | Testing the role of small RNAs in FMR1 promoter silencing in Fragile X Syndrome
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE/5R21NS087859-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2014/01/01 - 2015/12/31 | Genetic and pharmacologic inhibition of gene silencing in Fragile X stem cells
2013-034
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2014/01 - 2015/12 | Genetic and pharmacologic inhibition of gene silencing in Fragile X stem cells
2013-034
|
N/A |
2013/04/01 - 2015/03/31 | Mitigating chemotherapy-induced peripheral neuropathy by augmenting axonal NAD
info:eu-repo/grantAgreement/NIH/NATIONAL CANCER INSTITUTE/1R21CA176638-01/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2009/09/30 - 2014/08/31 | Novel fluorescent sensors for simple, sensitive, and specific protein detection
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING/5R01EB010249-03/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2009/07/01 - 2014/06/30 | Synthesis and Evaluation of NAD-augmenting Agents for Spinal Cord Injury
C023832
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
New York State Department of Health
Concluded
|
2009/07/01 - 2014/06/30 | Using stem cells to delineate the role of small RNAs in epigenetic reprogramming in fragile X
2008-019
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2007/04/04 - 2012/03/31 | Role of "Local" MicroRNAs and CGG Repeat-Derived RNAs in Fragile X Syndrome
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF MENTAL HEALTH/5R01MH080420-04/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2007/01/01 - 2011/12/31 | MicroRNAs in axonal pathfinding
Irma Hirschl-Weill Caulier Trust
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2009/12/03 - 2011/11/30 | Comprehensive profiling of ubiquitination in neurons
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF MENTAL HEALTH/5R21MH086128-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2007/09/30 - 2011/11/30 | Drug abuse signaling pathways that regulate CREB mRNA translation in dendrites
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE ON DRUG ABUSE/5R21DA023581-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2009/10/01 - 2011/09/30 | OptoTFs: Genetically encoded light-activated transcription factors
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE ON DRUG ABUSE/5RC1DA028556-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health |
2008/01/01 - 2010/12/31 | Use of axon-specific ablation of SMN to explore RNA dynamics in SMA
Spinal Muscular Atrophy Foundation
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Spinal Muscular Atrophy Foundation
Concluded
|
2007/02/01 - 2010/11/30 | Neuronal growth factor signaling via cAMP
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE/5R01NS055255-02/US
Researcher
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health |
2008/01/01 - 2009/12/31 | Design and application of biocompatible dendrimers for cancer therapy
Starr Cancer Consortium
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2006/07/01 - 2009/06/30 | Intra-axonal synthesis and retrograde trafficking of CREB in neuronal survival
Klingenstein Foundation
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Klingenstein Third Generation Foundation
Concluded
|
2007/07/01 - 2008/12/31 | Role of local RhoA mRNA translation in spine formation and mental retardation
March of Dimes
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
March of Dimes Foundation
Concluded
|
2006/01/15 - 2007/12/31 | Proteome-wide identification of protease targets
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES/5R21AI068639-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2006/01/15 - 2007/12/31 | Rapid ligand identification using HIV proteome microarrays
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES/5R21AI068512-02/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2006/01/01 - 2007/12/31 | Novel mRNA regulatory pathways underlying axon growth in SCI
SCIRB-031
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
New York State Department of Health
Concluded
|
2005/10/01 - 2007/10/31 | Role of TSC1/2 in axonal development and neuronal morphogenesis
Dept of Defense, Tuberous Sclerosis Concept
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
US Department of Defense
Concluded
|
2005/10 - 2007/10 | Role of TSC1/2 in axonal development and neuronal morphogenesis
Dept of Defense, Tuberous Sclerosis Concept
|
US Department of Defense |
2005/07/01 - 2007/06/30 | Role of RhoA translation in models of spinal cord injury
Christopher Reeve Paralysis Foundation
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Christopher and Dana Reeve Foundation
Concluded
|
2002/09/15 - 2007/06/30 | Detection and characterization of nitric oxide effectors
info:eu-repo/grantAgreement/NIH/NATIONAL INSTITUTE OF MENTAL HEALTH/5R01MH066204-03/US
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
National Institutes of Health
Concluded
|
2005/03/01 - 2007/02/28 | Molecular mechanisms of cytoskeletal regulation by FMRP
Fragile X Research Foundation (FRAXA)
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2004/07/01 - 2006/06/30 | Analysis of Synaptogenesis Signal Transduction Pathways that are Defective in Autism Spectrum Disorders
National Alliance for Autism Research
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Concluded
|
2000/07/01 - 2004/06/30 | Nitric Oxide and S-Nitrosylation in NMDA Receptor Signaling Dysfunction in Schizophrenia
National Alliance for Research on Schizophrenia and Depression
Principal investigator
Weill Cornell Medicine Department of Pharmacology, United States
|
Brain and Behavior Research Foundation |
Outputs
Publications
Book chapter |
|
Journal article |
|
Intellectual property
Patent |
|
Activities
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2019 - Current | Journal editorial board: F1000 Chemical Biology Faculty
Other
|
Faculty of 1000 Ltd, United Kingdom |
2015 - Current | Award Juries: Blavatnik Award for Young Scientists
Member
|
|
2006 - Current | Ad hoc reviewer for: ACS Chemical Biology, Analytical Biochemistry, Bioorganic & Medicinal Chemistry Letters, Brain Research, Cell, Chemical Science, Chemistry & Biology, eLife, Journal of the American Chemical Society, Journal of Biological Chemistry, Journal of Cell Biology, Journal of Neurochemistry, Journal of Neuroscience, Neuroscience, Nature, Nature Cell Biology, Nature Chemical Biology, Nature Neuroscience, Nature Methods, Nature Reviews Neuroscience, Neuron, PLoS Biology, Proceedings of the National Academy of Sciences, U.S.A., Science. | |
2004 - Current | Grant Review Service: United States-Israel Binational Science foundation; National Science Foundation; Human Frontiers Science
Program; Wings for Life Spinal Cord Research Foundation; National Institutes of Health Study Section Panels (Ad hoc member
and co-chair)
Other
|
|
2002 - Current | present Editorial Board, Technology in Cancer Research and Treatment
Other
|
|
2012 - 2017 | Editorial Board, Translation
Other
|
Consulting
Activity description | Institution / Organization | |
---|---|---|
2015/01 - 2015/01 | Working group for “NIH research plan on Fragile X Syndrome and Associated Disorders” and “NIH Common Fund Epitranscriptomics,” | National Institutes of Health, United States |
2014/09 - 2014/09 | Workshop Chair, NCI Workshop on RNA Editing, Epitranscriptomics, and Processing in Cancer Progression | National Cancer Institute, United States |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2005 - Current | 2nd year medical student Pharmacology lecture, “Drugs that act on the enteric nervous system” | Pharmacology (Bachelor) | Weill Cornell Medicine, United States |
2003 - Current | Graduate School, Course co-director, Critical Analysis of the Scientific Literature in Pharmacology, nine lectures, Quarter I-II | Pharmacology (Licence) | Weill Cornell Medicine, United States |
2002 - Current | Graduate school, Course co-director, Signal Transduction, Quarter II | Signal Transduction (Licence) | Weill Cornell Medicine, United States |
2002 - Current | Frontiers in Biomedical Sciences (MD/PhD course), One lecture, Quarter I | (Doctor) | Weill Cornell Medicine, United States |
2002 - Current | Graduate school, Cancer pharmacology, “Gene analysis and biomarker discovery in cancer.” | Cancer pharmacology (Licence) | Weill Cornell Medicine, United States |
2001 - Current | 2nd year medical student small group, Brain and Mind, Small Group: “Parkinson’s Pharmacotherapy” | Medicine (Bachelor) | Weill Cornell Medicine, United States |
2001 - Current | Graduate School, Lecturer, Logic & Experimental Design: “Proteomics”, Quarter II | Medicine (Licence) | Weill Cornell Medicine, United States |
2005 - 2009 | 1st year medical student Host Defenses lecture: “Drug Approval/discovery”, 1 lecture | (Bachelor) | Weill Cornell Medicine, United States |
2007 - 2007 | 2nd year medical student Brain and Mind lecture, “Neurotrophins” | (Bachelor) | Weill Cornell Medicine, United States |
2002 - 2005 | Graduate school, Course co-director, lecturer (six lectures), Chemical Biology, Quarter 1 | Chemical Biology (Licence) | Weill Cornell Medicine, United States |
2001 - 2005 | 1st year medical student group, Molecules to Cells “Abl” | Medicine (Bachelor) | Weill Cornell Medicine, United States |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2018 - Current | Qian Hou, Hyaeyeong Kim, Jacob Litke, Jared Moon, Christina Kam | |
2014 - 2018 | Grozhik, Anya | |
2010 - 2014 | Harkcom, William | |
2006 - 2012 | Walker, Breset | |
2006 - 2012 | Deglincerti, Alessia | |
2006 - 2012 | Lundquist, Mark | |
2005 - 2011 | Paige, Jeremy | |
2002 - 2006 | Wu, Karen |
Distinctions
Award
2018 | American Diabetes Association Visionary Award |
2017 | John J. Abel Award
American Society for Pharmacology and Experimental Therapeutics, United States
|
2014 | Young Investigator Award
American Society for Biochemistry and Molecular Biology, United States
|
2014 | Siegel Family Award for Outstanding Medical Research |
2013 | Blavatnik Award for Young Scientists, 2013 |
2013 | NIH EUREKA Award
National Institutes of Health, United States
|
2009 | NIH Director's Transformative R01 Award
National Institutes of Health, United States
|
2006 | Postdoctoral Mentoring Award from the Weill Cornell Postdoctoral Association |
2005 | McKnight Foundation Technology Development Award |
2005 | “New York 40 under 40” award, Crane’s New York Business Magazine |
2004 | National Alliance for Research on Schizophrenia and Depression Young Investigator Award |
2003 | Essel Investigator Award, National Alliance for Research on Schizophrenia and Depression |
1999 | Hans Prochaska Research Prize
Johns Hopkins University, United States
|
1989 | National Merit Scholar |
Title
2016 | Greenberg-Starr Professor
Weill Cornell Medicine, United States
|
Other distinction
2017 | Elected Member, American Society of Clinical Investigation |
2016 | Method of the Year – Epitranscriptome Analysis.” Highlighted the foundational role of the first epitranscriptome mapping technology Meyer, K.D., et al., Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. |
2011 | All time top 10 ranking (since 2001) publication (for Paige et al., 2011)
Faculty of 1000 Ltd, United Kingdom
|
2006 | Klingenstein Fellow in Neuroscience |
2006 | Irma T. Hirschl Scholar |
1999 | Medical Scientist Training Program
Johns Hopkins University, United States
|